nach oben

International Journal of Clinical Oncology

Erschienen in:

01.04.2014 | Original Article

A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder

verfasst von: Zhulin Yang, Zhi Yang, Qiong Zou, Yuan Yuan, Jinghe Li, Daiqiang Li, Lufeng Liang, Guixiang Zeng, Senlin Chen

Erschienen in: International Journal of Clinical Oncology | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

The differences in clinical, pathological, and biological characteristics between adenocarcinoma (AC) and squamous cell/adenosquamous carcinoma (SC/ASC) of gallbladder cancer have not been well documented. This study is to compare the clinicopathological characteristics and FGFBP1 and WISP-2 expression between AC and SC/ASC patients.

Methods

We examined FGFBP1 and WISP-2 expression in 46 SC/ASC and 80 AC samples using immunohistochemistry and analyzed their correlations with clinicopathological characteristics.

Results

SC/ASCs occur more frequently in older patients and often correspond to larger tumor masses than ACs. Positive FGFBP1 and negative WISP-2 expression were significantly associated with lymph node metastasis and invasion of SC/ASCs and ACs. In addition, positive FGFBP1 and negative WISP-2 expression were significantly associated with differentiation and TMN stage in ACs. Univariate Kaplan–Meier analysis showed that either elevated FGFBP1 (p < 0.001) or lowered WISP-2 (p < 0.001) expression was closely associated with decreased overall survival in both SC/ASC and AC patients. Multivariate Cox regression analysis showed that positive FGFBP1 expression (p = 0.001) or negative WISP-2 expression (p = 0.035 for SC/ASC and p = 0.009 for AC) is an independent predictor of poor prognosis in both SC/ASC and AC patients. We also revealed that differentiation, tumor size, TNM stage, lymph node metastasis, invasion, and surgical procedure were associated with survival of both SC/ASC and AC patients.

Conclusion

Our study suggested that the overexpression of FGFBP1 or loss of WISP-2 expression is closely related to the metastasis, invasion and poor prognosis of gallbladder cancer.

Hsing AW, Gao WT, Han TQ et al (2007) Gallstones and the risk of biliary tract cancer: a population-based study in China. Br J Cancer 97:1577–1582PubMedCentralPubMedCrossRef

Ootani T, Shirai Y, Tsukada K et al (1992) Relationship between gallbladder carcinoma and the segmental type of adenomyomatosis of the gallbladder. Cancer 69:2647–2652PubMedCrossRef

Jayaraman S, Jarnagin WR (2010) Management of gallbladder cancer. Gastroenterol Clin North Am 39:331–342PubMedCrossRef

Roa JC, Tapia O, Cakir A et al (2011) Squamous cell and adenosquamous carcinomas of the gallbladder: clinicopathological analysis of 34 cases identified in 606 carcinomas. Mod Pathol 24:1069–1078PubMedCrossRef

Reid KM, Ramos-De la Medina A, Donohue JH (2007) Diagnosis and surgical management of gallbladder cancer: a review. J Gastrointest Surg 11:671–681PubMedCrossRef

de Aretxabala X, Roa I, Burgos L et al (2006) Gallbladder cancer: an analysis of a series of 139 patients with restricted to the subserosal layer. J Gastrointest Surg 10:186–192PubMedCrossRef

Park SB, Kim YH, Rho HL et al (2012) Primary carcinosarcoma of the gallbladder. J Korean Surg Soc 82:54–58PubMedCentralPubMedCrossRef

Maurya SK, Tewari M, Mishra RR et al (2012) Genetic aberrations in gallbladder cancer. Surg Oncol 21:37–43PubMedCrossRef

Wesche J, Haglund K, Haugsten EM (2011) Fibroblast growth factors and their receptors in cancer. Biochem J 437:199–213PubMedCrossRef

10.

Abuharbeid S, Czubayko F, Aigner A (2006) The fibroblast growth factor-binding protein FGF-BP. Int J Biochem Cell Biol 38:1463–1468PubMedCrossRef

11.

Cronauer MV, Schulz WA, Seifert HH et al (2003) Fibroblast growth factors and their receptors in urological cancers: basic research and clinical implications. Eur Urol 43:309–319PubMedCrossRef

12.

Begum S, Zhang Y, Shintani T et al (2007) Immunohistochemical expression of heparin-binding protein 17/fibroblast growth factor-binding protein-1 (HBp17/FGFBP-1) as an angiogenic factor in head and neck tumorigenesis. Oncol Rep 17:591–596PubMed

13.

Czubayko F, Smith RV, Chung HC et al (1994) Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J Biol Chem 269:28243–28248PubMed

14.

Aigner A, Renneberg H, Bojunga J et al (2002) Ribozyme-targeting of a secreted FGF-binding protein (FGF-BP) inhibits proliferation of prostate cancer cells in vitro and in vivo. Oncogene 21:5733–5742PubMedCrossRef

15.

Katoh M, Katoh M (2006) Cross-talk of WNT and FGF signaling pathways at GSK3beta to regulate beta-catenin and SNAIL signaling cascades. Cancer Biol Ther 5:1059–1064PubMedCrossRef

16.

Katoh M (2011) Network of WNT and other regulatory signaling cascades in pluripotent stem cells and cancer stem cells. Curr Pharm Biotechnol 12:160–170PubMedCrossRef

17.

Brigstock DR (2003) The CCN family: a new stimulus package. J Endocrinol 178:169–175PubMedCrossRef

18.

Davies SR, Davies ML, Sanders A et al (2010) Differential expression of the CCN family member WISP-1, WISP-2 and WISP-3 in human colorectal cancer and the prognostic implications. Int J Oncol 36:1129–1136PubMed

19.

Khor TO, Gul YA, Ithnin H et al (2006) A comparative study of the expression of Wnt-1, WISP-1, survivin and cyclin-D1 in colorectal carcinoma. Int J Colorectal Dis 21:291–300PubMedCrossRef

20.

Banerjee S, Dhar G, Haque I et al (2008) CCN5/WISP-2 expression in breast adenocarcinoma is associated with less frequent progression of the disease and suppresses the invasive phenotypes of tumor cells. Cancer Res 68:7606–7612PubMedCrossRef

21.

Banerjee S, Saxena N, Sengupta K et al (2003) WISP-2 gene in human breast cancer: estrogen and progesterone inducible expression and regulation of tumor cell proliferation. Neoplasia 5:63–73PubMedCentralPubMedCrossRef

22.

Nishihara K, Nagai E, Izumi Y et al (1994) Adenosquamous carcinoma of the gallbladder: a clinicopathological, immunohistochemical and flow-cytometric study of twenty cases. Jpn J Cancer Res 85:389–399PubMedCrossRef

23.

Kondo M, Dono K, Sakon M et al (2002) Adenosquamous carcinoma of the gallbladder. Hepatogastroenterology 49:1230–1234PubMed

24.

Oohashi Y, Shirai Y, Wakai T et al (2002) Adenosquamous carcinoma of the gallbladder warrants resection only if curative resection is feasible. Cancer 94:3000–3005PubMedCrossRef

Titel: A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder
verfasst von: Zhulin Yang
Zhi Yang
Qiong Zou
Yuan Yuan
Jinghe Li
Daiqiang Li
Lufeng Liang
Guixiang Zeng
Senlin Chen
Publikationsdatum: 01.04.2014
Verlag: Springer Japan
Erschienen in: International Journal of Clinical Oncology / Ausgabe 2/2014
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI: https://doi.org/10.1007/s10147-013-0550-9

Springer Medizin

A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder